English  |  正體中文  |  简体中文  |  Items with full text/Total items : 43312/67235
Visitors : 2051584      Online Users : 47
RC Version 5.0 © Powered By DSPACE, MIT. Enhanced by NTU/NCHU Library IR team.
National Chung Hsing University Institutional Repository - NCHUIR > 生命科學院 > 生命科學院 > 依資料類型分類 > 碩博士論文 >  藉由剔除CD25調節性T細胞增強EGFR DNA疫苗對抗EGFR大量表現之轉移性肺癌

Please use this identifier to cite or link to this item: http://nchuir.lib.nchu.edu.tw/handle/309270000/152181

標題: 藉由剔除CD25調節性T細胞增強EGFR DNA疫苗對抗EGFR大量表現之轉移性肺癌
Enhancing efficacy of therapeutic EGFR DNA vaccine by depletion of CD25+ regulatory T cell in a mouse model of metastatic EGFR positive lung cancer
作者: 陳杏燕
Chen, Hsing-Yen
Contributors: 林季千
Chi-Chen Lin
生命科學院碩士在職專班
關鍵字: 轉移性肺癌;CD25調節性T細胞;CD8+;CTL
metastatic lung cancer;CD25+ regulatory T cell;CD8+;CTL
日期: 2012
Issue Date: 2013-11-07 13:14:34 (UTC+8)
Publisher: 生命科學院碩士在職專班
摘要: 肺癌指的是肺部組織內細胞生長失去控制的疾病。這種細胞生長可能造成轉移,就是侵入相鄰的組織和滲透到肺部意外。絕大多數肺癌是肺部惡性上皮細胞腫瘤,由上皮細胞病變而造成。肺癌是造成男性和女性癌症相關死亡的最主要原因。全球每年有130萬人死於肺癌。先前,我們報告在細胞外域經由操作基因槍送入naked DNA Plasmid coding的異種表皮生長因子受體,可誘發強烈的CTL活性和控制內源性表皮生長因子受體表現在小鼠皮下腫瘤LL2肺腫瘤的增長。然而,我們目前的研究顯示,操作基因槍送入EGFR DNA缺乏有效的治療患有轉移性LL2肺腫瘤的小鼠。而調節性T細胞 ( Tregs ) 對腫瘤免疫反應發揮重要的作用。因此,我們進一步確定是否利用CD25消耗抗體PC61剔除CD25 T細胞,增強DNA疫苗對抗轉移性肺腫瘤LL2的生長。我們發現,結合PC61的EGFR DNA疫苗顯著降低肺腫瘤的生長。在研究淋巴結細胞毒活性的結果顯示,結合PC61的EGFR DNA疫苗對於治療抗腫瘤作用和增加功能性CD8+ T細胞與CTL活性,有顯著的關連。
此外,在體內淋巴細胞耗竭實驗進一步證實,EGFR DNA疫苗與PC61抗體結合的療效是依賴於CD8+ T細胞。因此由這些觀察的結果顯示,可以經由操作基因槍送入EGFR DNA疫苗結合剔除CD25 T細胞的抗體,增加對大量表現EGFR之轉移性肺腫瘤的療效
Previously, we reported that gene gun administration with naked DNA plasmids coding for the extracellular domains of the xenogenic EGFR gene can induce strong CTL activity and control endogenous EGFR -expressing LL2 lung tumors growth in subcutaneous tumor models in mice. However, our present study observed that gene gun administration EGFR DNA vaccines alone lack of effective against lung metastatic LL2 tumor in mouse model was established experimentally by an intravenous injection of tumors. Since regulatory T cells (Tregs) play an important role in immunosuppressive responses against tumors by immunotherapy. Thus, we further determine whether break suppressing immune responses by depletion of CD25+ Treg cells using CD25 depleting Ab PC61 would enhance the efficacy of DNA vaccine against metastatic LL2 lung tumor growth. We found that combination of EGFR DNA vaccine with PC61 vaccination significantly reduce the tumor growth in lung and prolong mice over either modality alone. In estimation of cytotoxicity activity studies of the lymph nodes revealed that therapeutic antitumor effect of combination with EGFR DNA vaccine and PC61 is associated with a significant increased the number of functional CD8+ T cell and level of CTL activity. Furthermore, in vivo lymphocyte depletion experiments further confirmed that the efficacy of combining with EGFR DNA vaccine and PC61 Ab, is dependent on CD8+ T cells. Thus, these observations suggest that increased therapeutic efficacy against metastatic EGFR positive lung tumor could be obtained by combining gene gun administration of naked DNA vaccine and depletion of CD25 Treg cells by using depleting antibody.
Appears in Collections:[依資料類型分類] 碩博士論文

Files in This Item:

File Description SizeFormat
index.html0KbHTML103View/Open
nchu-101-5098052026-1.pdf930Kb270View/Open


 


學術資源

著作權聲明

本網站為收錄中興大學學術著作及學術產出,已積極向著作權人取得全文授權,並盡力防止侵害著作權人之權益。如仍發現本網站之數位內容有侵害著作權人權益情事者,請權利人通知本網站維護人員,將盡速為您處理。

本網站之數位內容為國立中興大學所收錄之機構典藏,無償提供學術研究與公眾教育等公益性使用。

聯絡網站維護人員:wyhuang@nchu.edu.tw,04-22840290 # 412。

DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU/NCHU Library IR team Copyright ©   - Feedback